Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria

Arienne Mirmiran; Antoine Poli; Cecile Ged; Caroline Schmitt; Thibaud Lefebvre; Hana Manceau; Raêd Daher; Boualem Moulouel; Katell Peoc'h; Sylvie Simonin; Jean-Marc Blouin; Jean-Charles Deybach; Gaël Nicolas; Hervé Puy; Emmanuel Richard; Laurent Gouya

doi:10.3324/haematol.2019.228270

Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria

Haematologica. 2021 Mar 1;106(3):913-917. doi: 10.3324/haematol.2019.228270.

Authors

Arienne Mirmiran¹, Antoine Poli^{1

2}, Cecile Ged^{3

4}, Caroline Schmitt^{1

2}, Thibaud Lefebvre^{1

2}, Hana Manceau^{1

5

6}, Raêd Daher^{1

2}, Boualem Moulouel², Katell Peoc'h^{1

5

6}, Sylvie Simonin^{1

2}, Jean-Marc Blouin^{3

4}, Jean-Charles Deybach^{1

2}, Gaël Nicolas¹, Hervé Puy^{1

2}, Emmanuel Richard^{3

4}, Laurent Gouya^{1

2

4}

Affiliations

¹ Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherches sur l’Inflammation, Paris
² Assistance Publique-Hôpitaux de Paris, Centre Français des Porphyries, Hôpital Louis Mourier, Colombes
³ Université Bordeaux, INSERM, BMGIC, U1035, CHU Bordeaux, Bordeaux
⁴ Laboratory of Excellence Gr-Ex, Paris
⁵ Université de Paris, Paris
⁶ Assistance Publique-Hôpitaux de Paris, HUPNVS, Laboratoire de Biochimie, Hôpital Beaujon, Clichy, France

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Phlebotomy
Porphyria, Erythropoietic* / diagnosis
Porphyria, Erythropoietic* / therapy

Grants and funding

Funding; this study was supported by a grant from Laboratory of Excellence GR-Ex, reference ANR-11-LABX-0051. AM was supported by a Labex GR-Ex scholarship. The Labex GR-Ex is funded by the program ‘‘Investissements d’avenir’’ of the French National Research Agency, reference ANR-11-IDEX-0005-02.